Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore B Moore

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Lancet (London, England)|June 23, 2023
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment ConsortiumMonica S Thakar, Brent R Logan, Jennifer M Puck, et al.
Blood|August 10, 2023
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGDJennifer W Leiding, Danielle E Arnold, Suhag Parikh, et al.
Blood Advances|December 5, 2025
Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC ReportJessie L Alexander, Blachy J Dávila Saldaña, Ruta Brazauskas, et al.
Journal of Human Immunity|July 8, 2026
Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC reportLena E Winestone, Brent R Logan, Xuerong Liu, et al.
JAMA|August 21, 2014
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United StatesAntonia Kwan, Roshini S Abraham, Robert Currier, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Lancet (London, England)|June 23, 2023
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment ConsortiumMonica S Thakar, Brent R Logan, Jennifer M Puck, et al.
Blood|August 10, 2023
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGDJennifer W Leiding, Danielle E Arnold, Suhag Parikh, et al.
Blood Advances|December 5, 2025
Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC ReportJessie L Alexander, Blachy J Dávila Saldaña, Ruta Brazauskas, et al.
Journal of Human Immunity|July 8, 2026
Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC reportLena E Winestone, Brent R Logan, Xuerong Liu, et al.
JAMA|August 21, 2014
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United StatesAntonia Kwan, Roshini S Abraham, Robert Currier, et al.
Pageof 9